Skip to main content

Table 2 Effect of dietary vitamin K (VK) supplementation and Salmonella Enteritidis (SE) challenge on laying performance of laying hens (n = 20)

From: Vitamin K alleviates bone calcium loss caused by Salmonella Enteritidis through carboxylation of osteocalcin

VK, mg/kg

SEc

Laying rate, %

Daily egg mass, g

Egg weight, g

Daily feed intake, g/d/bird

Feed conversion, g/g

Broken eggs, %

Mortality, %

Week

32–42

Week

43–44

Week

32–42

Week

43–44

Week

32–42

Week

43–44

Week

32–42

Week

43–44

Week

32–42

Week

43–44

Week

32–42

Week

43–44

Week

32–42

Week

43–44

0

–

92.6

87.1

55.24

52.49

59.62

60.23

116.91

101.20

2.11

1.93

3.16

0.00

11.9

18.4

0

+

 

84.5

 

50.64

 

59.99

 

99.32

 

1.96

 

0.00

 

26.6

2

–

94.5

92.4

56.75

55.92

60.06

60.49

114.83

105.23

2.03

1.89

2.08

3.45

5.0

18.4

2

+

 

90.8

 

54.49

 

60.08

 

106.78

 

1.96

 

0.00

 

26.6

 

SEMd

0.986

2.600

0.646

1.506

0.338

0.646

2.715

3.449

0.061

0.039

0.725

1.026

3.708

0.000

0

 

–

85.8b

–

51.56b

–

60.11

–

100.26

–

1.95

–

0.00

–

22.5

2

 

–

91.6a

–

55.21a

–

60.28

–

106.01

–

1.92

–

1.72

–

22.5

 

SEMd

–

1.839

–

1.065

–

0.457

–

2.439

–

0.028

–

0.726

–

0.000

 

–

–

89.8

–

54.21

–

60.36

–

103.21

–

1.91

–

1.72

–

18.4b

 

+

–

87.6

–

52.57

–

60.03

–

103.06

–

1.96

–

0

–

26.6a

 

SEMd

–

1.839

–

1.065

–

0.457

–

2.439

–

0.028

–

0.726

–

0.000

 

VK

0.215

0.046

0.130

0.032

0.381

0.794

0.600

0.121

0.379

0.578

0.316

0.119

0.216

–

P-values3

SE

–

0.419

–

0.297

–

0.619

–

0.965

–

0.207

–

0.119

–

< 0.010

 

VK × SE

–

0.846

–

0.890

–

0.901

–

0.627

–

0.578

–

0.119

–

–

  1. a, bMeans within a column with no common superscripts differ (P < 0.05)
  2. cSE Salmonella Enteritidis; –, without SE challenge; +, with SE challenge
  3. dSEM Pooled standard error of the mean
  4. 3P-values for main effect of VK, the main effect of SE challenge, and the interaction between the VK treatments and SE challenge